000423.SZ
东阿阿胶
SZSE · Healthcare · C 制造业 · CN
CNY 48.00
−0.72%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 6.8B | 6.7B | 6.2B | 4.7B | 4.0B |
| Cost of Revenue | 1.8B | 1.8B | 1.9B | 1.4B | 1.3B |
| Gross Profit | 5.0B | 4.9B | 4.3B | 3.3B | 2.8B |
| Operating Expenses | |||||
| R&D Expense | 284.5M | 272.4M | 173.8M | 173.2M | 137.7M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 490.6M | 482.9M | 446.1M | 377.3M | 387.2M |
| Selling & Marketing Expense | 2.2B | 2.1B | 2.0B | 1.5B | 1.3B |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 3.0B | 2.9B | 2.6B | 2.0B | 1.8B |
| Cost and Expenses | 4.8B | 4.7B | 4.4B | 3.4B | 3.1B |
| Operating Income (EBIT) | 2.1B | 2.1B | 1.8B | 1.4B | 914.9M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 2.1B | 2.1B | 1.9B | 1.4B | 912.0M |
| Income Tax Expense | 319.4M | 321.3M | 298.8M | 210.9M | 132.8M |
| Bottom Line | |||||
| Net Income | 1.8B | 1.7B | 1.6B | 1.2B | 780.0M |
| Earnings from Cont. Ops | 1.8B | 1.7B | 1.6B | 1.2B | 779.2M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 1.8B | 1.7B | 1.6B | 1.2B | 780.0M |
| Per Share | |||||
| Basic EPS | CN¥2.75 | CN¥2.70 | CN¥2.42 | CN¥1.79 | CN¥1.21 |
| Diluted EPS | CN¥2.75 | CN¥2.70 | CN¥2.42 | CN¥1.79 | CN¥1.21 |
| Revenue Per Share | CN¥10.58 | CN¥10.40 | CN¥9.57 | CN¥7.33 | CN¥6.27 |
| Shares | |||||
| Basic Shares Outstanding | 642.4M | 644.0M | 643.4M | 642.9M | 644.6M |
| Diluted Shares Outstanding | 642.4M | 644.0M | 643.4M | 642.9M | 644.6M |
| Profitability Metrics | |||||
| EBITDA | — | 2.2B | 2.0B | 1.5B | 1.1B |
| D&A | — | 135.8M | 138.4M | 143.3M | 150.1M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026